Form 4: Xylem EVP Yarkadas Reports Equity Awards & Vesting

Xylem Inc.'s EVP & President, WI, Hayati Yarkadas, reported the vesting of performance-based stock units and the award of new restricted stock units and stock options.

Summary

• Hayati Yarkadas, EVP & President, WI, acquired 4,456 shares of Xylem common stock on March 1, 2026, upon vesting of performance-based stock units tied to Total Shareholder Return.
• Acquired an additional 3,679 shares on March 1, 2026, from performance-based stock units linked to Adjusted EBITDA.
• Further acquired 2,501 shares on March 1, 2026, from performance-based stock units based on Revenue achievement.
• Acquired 1,761 shares on March 1, 2026, from performance-based stock units related to ESG performance.
• Received an award of 2,274 restricted stock units on March 2, 2026, which are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
• Was awarded 8,102 non-qualified stock options on March 2, 2026, with an exercise price of $128.98, vesting in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029, and expiring on March 2, 2036.
• Disposed of a total of 776 shares of common stock on March 2, 2026, to cover tax liabilities associated with the vesting of various stock units.
• Following these transactions, Hayati Yarkadas beneficially owns 33,581 shares of common stock and 8,102 non-qualified stock options.
• All equity transactions were conducted under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing, reflecting the achievement of performance targets and the ongoing commitment of an executive through new long-term equity awards, which are standard positive indicators of executive alignment.

Positives

• Achievement of performance criteria for Total Shareholder Return, Adjusted EBITDA, Revenue, and ESG performance, leading to the vesting of performance-based stock units.
• Grant of new restricted stock units and non-qualified stock options indicates continued incentive and alignment with company performance.
• Beneficial ownership includes additional shares due to dividend reinvestment, suggesting a positive return on existing holdings.

Negatives

• Disposal of 776 shares to cover tax liabilities, which is a standard practice for equity compensation but reduces direct shareholding.

Future Outlook

The award of new restricted stock units and non-qualified stock options with future vesting schedules extending to March 2029 indicates a long-term incentive structure for the executive, aligning future performance with shareholder interests.

Industry Context

StockSavvy.ai notes that equity compensation, particularly performance-based awards and restricted stock units with multi-year vesting, is a standard practice across industries to align executive incentives with long-term company performance and shareholder value creation. This filing reflects Xylem's continued use of such mechanisms to retain and motivate key executives.

Comparison to Industry Standards

• StockSavvy.ai observes that Xylem's use of performance-based stock units tied to metrics like Total Shareholder Return, Adjusted EBITDA, Revenue, and ESG performance aligns with best practices in executive compensation seen in leading industrial and water technology companies such as Danaher Corporation (DHR), Ecolab Inc. (ECL), and Pentair plc (PNR).
• These companies also frequently utilize multi-year vesting schedules for restricted stock and options to foster long-term commitment and performance.

Stakeholder Impact

• Shareholders: The vesting of performance-based awards indicates the company met certain performance targets (TSR, EBITDA, Revenue, ESG), which is generally positive for shareholders. The new equity awards align executive incentives with long-term shareholder value.
• Employees: N/A (Specific impact on general employees not detailed in this Form 4).
• Customers: N/A (Specific impact on customers not detailed in this Form 4).
• Suppliers: N/A (Specific impact on suppliers not detailed in this Form 4).
• Creditors: N/A (Specific impact on creditors not detailed in this Form 4).

Next Steps

• First vesting increment for restricted stock units and non-qualified stock options on March 1, 2027.
• Second vesting increment for restricted stock units and non-qualified stock options on March 1, 2028.
• Third vesting increment for restricted stock units and non-qualified stock options on March 1, 2029.
• Expiration of non-qualified stock options on March 2, 2036.

Key Dates

Recommendation

This Form 4 filing details routine executive equity compensation activities, including the vesting of performance-based awards and the grant of new long-term incentives. While the achievement of performance targets is positive, these are standard occurrences for an executive and do not present new information that would significantly alter the investment thesis for Xylem Inc. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Xylem Inc., XYL, Hayati Yarkadas, Form 4, Insider Transaction, Stock Units, Stock Options, Equity Compensation, Performance-Based Awards, Restricted Stock Units, Total Shareholder Return, Adjusted EBITDA, Revenue, ESG Performance, Omnibus Incentive Plan